(¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ º´Çà) Á¦13Â÷ ´ëÇÑÁ¾¾ç³»°úÇÐȸ Çмú´ëȸ ¹× 2020 ±¹Á¦Çмú´ëȸ : 2020-09-04±³À°ÀÏÀÚ : 2020-09-04
±³À°Àå¼Ò : ¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ ¿¬¼ö±³À° (¿ÀÇÁ¶óÀÎ: µå·¡°ï¾¾Æ¼ ÇѶó·ë ¿Ü)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ º´Çà) Á¦13Â÷ ´ëÇÑÁ¾¾ç³»°úÇÐȸ Çмú´ëȸ ¹× 2020 ±¹Á¦Çмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : °ÇØÁø
¿¬¶ôó : 02-735-2857
À̸ÞÀÏ :
ksmo3@ksmo.or.kr ±³À°Á¾·ù : ³»°ú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°úÀÇ·áÁ¤Ã¥,
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 08:00~08:20 Developing new target agents in colorectal cancer (RAS/RAF) Scott KOPETZ(The University of Texas MD Anderson Cancer Center USA)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 08:20~08:40 Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy Â÷¿ëÁØ(±¹¸³¾Ï¼¾ÅÍ )
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 08:40~09:00 Neoadjuvant chemotherapy in operable colon cancer À̼öÇö(°í·Á´ëÇб³)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 09:00~09:15 Learning about carcinogenesis and drug sensitivity from organoids Shiladitya SENGUPTA(Harvard Medical School USA)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 09:15~09:30 Clinical application of organoids for cancer diagnosis and treatment ÁÖ¿µ¼®(Çѱ¹°úÇбâ¼ú¿ø)
Åä·Ð 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 09:30~09:40 Panel Discussion -(-)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 09:40~09:55 Microbiota, immune-tonus, and cancer: Biology Thomas F. GAJEWSKI(The University of Chicago USA)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 09:55~10:15 Microbiota, immune-tonus, and cancer: Clinical applications Siew C NG(The Chinese University of Hong Kong Hong Kong)
Åä·Ð 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 10:15~10:30 Panel Discussion -(-)
ÈÞ½Ä 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 10:30~10:50 ()
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 10:50~11:30 Therapeutic targeting of the TAM receptor family in cancer Amato Giaccia(Oxford Institute of Radiation Oncology UK)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 11:30~12:10 Clinical investigation for the management of advanced gastrointestinal stromal tumor (GIST) °À±±¸(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 12:10~12:50 Treatment landscape for HR+/HER2- aBC: Focusing on CDK4/6 pathway TBD(TBD)
ÈÞ½Ä 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 12:50~13:20 ()
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 13:20~13:40 Collaboration with multinational study groups Kun WANG(Guangdong Provincial People)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 13:40~14:00 Conducting clinical trials with multi-disciplinary collaboration ¼ÕÁÖÇõ(¿¬¼¼¾Ïº´¿ø)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 14:00~14:20 Early phase clinical trials: Win-win strategies for investigator and company ÀÌ»óÀ±(ÀÎÅÍÆÄÅ© ¹ÙÀÌ¿ÀÀ¶ÇÕ¿¬±¸¼Ò)
ÈÞ½Ä 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 14:20~14:40 ()
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 14:40~15:00 Clinical relevance of genomics in cancer medicine in Japan Koichi GOTO(National Cancer Center Hospital East Japan)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 15:00~15:20 Implementation of genomics in medical practice in Korea À̼¼ÈÆ(¼º±Õ°ü ÀÇ´ë)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 15:20~15:40 Cancer immunogenomics Yosuke TOGASHI(Chiba Cancer Center Japan)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 15:40~16:00 Application of single cell genomics in precision medicine ¹Ú¿õ¾ç(»ï¼ºÀ¯Àüü¿¬±¸¼Ò)
ÈÞ½Ä 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 16:00~16:20 ()
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 16:20~16:40 Prospects for immunotherapy and targeted therapy in gastric cancer ¿Àµµ¿¬(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 16:40~17:00 Promising new treatments in biliary tract cancer ¹ÚÁØ¿À(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 17:00~17:20 Further treatment strategies beyond PARPi therapy in pancreatic cancer Li-Tzong CHEN(National Institute of Cancer Research Taiwan)
±³À°½Ã°£ 09¿ù 04ÀÏ Room A (¿Â/¿ÀÇÁ¶óÀκ´Çà) 17:20~17:40 Challenges in systemic therapy in hepatocellular carcinoma ·ù¹é·Ä(¼¿ï¾Æ»êº´¿ø)